Skip to content

An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05087680
Enrollment
66
Registered
2021-10-21
Start date
2023-09-14
Completion date
2026-06-16
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Prevention

Keywords

ACT, PrEP

Brief summary

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP.

Detailed description

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP. Specific Aim 1) Gather data from YBMSM (n = 20) and clinic staff (n = 10) through in-depth interviews to assess quantitative measures, intervention design, and experiences most relevant to PrEP engagement. Specific Aim 2) Develop ACTPrEP utilizing Aim 1 data, working iteratively with experts, and an intervention "run through" with a sample of participants. CLINICAL TRIAL IS AIM 3 ONLY Specific Aim 3) Evaluate ACTPrEP. Enroll 66 participants. Primary outcomes will be feasibility (measured by percentage eligible, consented, randomized, and retained) and acceptability (measured by the Client Satisfaction Questionnaire). Secondary outcomes will compare ACTPrEP vs. enhanced standard of care condition (ESOC) on behavior outcomes (uptake, adherence, and PrEP persistence) and possible mediators over the course of 24 weeks. Barriers and facilitators to implementing ACTPrEP will be assessed with post-RCT qualitative interviews using the i-PARIHS framework.

Interventions

BEHAVIORALACTPrEP

ACTPrEP will include a 60-minute initial session and a series of 30-minute follow-up sessions. Sessions will focus on the Thoughts, Emotions, Associations, Memories, and Sensations (TEAMS) relevant to PrEP uptake and adherence.

BEHAVIORALEnhanced Standard of Care

Enhanced Standard of Care (ESOC) will include one 30-minute PrEP education session.

Sponsors

Rhode Island Hospital
Lead SponsorOTHER
University of Mississippi Medical Center
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 34 Years
Healthy volunteers
Yes

Inclusion criteria

* English speaking * Between 18-34 years old * Male sex assigned at birth * Identify as African American/Black * Not enrolled in another PrEP related study * Able to give consent * Not taken PrEP in past 3 months * Report having sex with a man in the past 3 months * PrEP-eligible according to CDC guidelines

Exclusion criteria

* Participating in another PrEP study * Unable to provide consent

Design outcomes

Primary

MeasureTime frameDescription
ACTPrEP Feasibility12 week visitACTPrEP feasibility is measured by percentage of participants retained in the study.
ACTPrEP Acceptability12 week visitAcceptability is measured with the Client Satisfaction Questionnaire.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORTrisha Arnold, PhD

Rhode Island Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026